Bora Pharmaceuticals has acquired Upsher-Smith Laboratories, a generics manufacturer based in Minnesota, for up to $210 million, pending approval. Upsher-Smith, founded in 1919 and owned by the Japanese firm Sawai Group since 2017, has a portfolio of 48 generic products with manufacturing facilities in Plymouth and Maple Grove in Minnesota. Combined, the two manufacturing facilities in Minnesota are capable of commercializing a broad range of dosage forms including oral solid, powders (bot...